The Effect of ESWT in Carpal Tunnel Syndrome
ESWT
Effect of Extracorporeal Shock Wave Therapy on Carpal Tunnel Syndrome
1 other identifier
interventional
50
1 country
1
Brief Summary
50 patients who meet the inclusion criteria will be included in this prospective, randomized and controlled study. Demographic information of the patients will be taken and recorded. After the patients are numbered according to the order of application, they will be divided into 2 groups as study and control groups according to randomization with the computer program. A total of 5 sessions of ESWT (1000 shock, 1.6 bar, 5 Hz) will be applied to the study group (1st group) for 2 weeks. Patients will be taught median nerve and tendon shifting exercises and will be asked to do it regularly. Patients in the control group (Group 2) will be asked to perform median nerve and tendon shifting exercises only for the wrist. Patients will be evaluated before treatment, at 4 and 12 weeks after treatment. In the evaluation, Boston Carpal Tunnel Inquiry Form, pain severity assessment with VAS (visual analog scale), neuropathic pain intensity with LANSS scale and median nerve conduction velocity with EMG will be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 13, 2021
CompletedFirst Posted
Study publicly available on registry
May 21, 2021
CompletedStudy Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2021
CompletedMarch 20, 2023
March 1, 2023
3 months
May 13, 2021
March 16, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Boston carpal tunnel questionnaire
The functional levels of the patients will be evaluated with the Boston carpal tunnel questionnaire.
3 months
Secondary Outcomes (2)
Visual Analog Scale
3 months
Median nerve conduction study
3 months
Study Arms (2)
ESWT Group
EXPERIMENTALA total of 5 sessions of ESWT (1000 shock, 1.6 bar, 5 Hz) will be applied to the patients in this group for 2 weeks. Median nerve and tendon shifting exercises will be taught to the patients and they will be asked to do it regularly.
Control Group
NO INTERVENTIONPatients in the control group will be asked to do median nerve and tendon shifting exercises only for the wrist.
Interventions
In the study group, a total of 5 sessions of focused ESWT (1000 shock, 1.6 bar, 5 Hz) will be applied to the affected wrist within 2 weeks.
Eligibility Criteria
You may qualify if:
- Patients with a diagnosis of mild to moderate CTS in the nerve conduction study within the last 1 month,
- Positive Phalen and Tinnel tests in clinical examination
- Who agreed to participate in the study
You may not qualify if:
- Patients with cervical radiculopathy,
- Pregnant women,
- Rheumatoid arthritis,
- Thenar atrophy,
- Steroid injection or surgical procedure in the wrist in the last 3 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ahmet Kıvanç Menekşeoğlu
Istanbul, 34015, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ahmet K Menekşeoğlu
Kanuni Sultan Süleyman Research and Training Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- The evaluation of the patients will be made by an evaluator who has no knowledge of group distribution.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 13, 2021
First Posted
May 21, 2021
Study Start
June 1, 2021
Primary Completion
September 1, 2021
Study Completion
November 1, 2021
Last Updated
March 20, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share
Identity information of the patients other than their gender, age and BMI will not be shared.